Ovid Therapeutics Inc (OVID)
3.06
-0.01
(-0.33%)
USD |
NASDAQ |
May 03, 16:00
3.04
-0.02
(-0.65%)
After-Hours: 20:00
Ovid Therapeutics Market Cap: 216.37M for May 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 03, 2024 | 216.37M |
| May 02, 2024 | 217.08M |
| May 01, 2024 | 216.37M |
| April 30, 2024 | 215.67M |
| April 29, 2024 | 236.17M |
| April 26, 2024 | 219.20M |
| April 25, 2024 | 211.42M |
| April 24, 2024 | 222.74M |
| April 23, 2024 | 226.27M |
| April 22, 2024 | 222.74M |
| April 19, 2024 | 228.39M |
| April 18, 2024 | 226.98M |
| April 17, 2024 | 219.91M |
| April 16, 2024 | 224.15M |
| April 15, 2024 | 226.27M |
| April 12, 2024 | 226.27M |
| April 11, 2024 | 231.22M |
| April 10, 2024 | 224.86M |
| April 09, 2024 | 229.10M |
| April 08, 2024 | 227.69M |
| April 05, 2024 | 229.81M |
| April 04, 2024 | 215.67M |
| April 03, 2024 | 215.67M |
| April 02, 2024 | 215.67M |
| April 01, 2024 | 218.49M |
| Date | Value |
|---|---|
| March 28, 2024 | 215.67M |
| March 27, 2024 | 215.67M |
| March 26, 2024 | 212.13M |
| March 25, 2024 | 218.49M |
| March 22, 2024 | 226.27M |
| March 21, 2024 | 215.67M |
| March 20, 2024 | 197.28M |
| March 19, 2024 | 194.45M |
| March 18, 2024 | 193.04M |
| March 15, 2024 | 192.33M |
| March 14, 2024 | 194.45M |
| March 13, 2024 | 199.40M |
| March 12, 2024 | 200.11M |
| March 11, 2024 | 207.89M |
| March 08, 2024 | 217.79M |
| March 07, 2024 | 224.15M |
| March 06, 2024 | 229.81M |
| March 05, 2024 | 231.22M |
| March 04, 2024 | 236.11M |
| March 01, 2024 | 240.35M |
| February 29, 2024 | 240.35M |
| February 28, 2024 | 242.47M |
| February 27, 2024 | 256.61M |
| February 26, 2024 | 260.15M |
| February 23, 2024 | 261.56M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
61.52M
Minimum
May 30 2019
470.36M
Maximum
Aug 19 2020
213.15M
Average
221.98M
Median
Nov 26 2021
Market Cap Benchmarks
| Ligand Pharmaceuticals Inc | 1.308B |
| NovaBay Pharmaceuticals Inc | 2.856M |
| Palatin Technologies Inc | 34.05M |
| iBio Inc | 6.934M |
| Theriva Biologics Inc | 6.911M |
Market Cap Related Metrics
| PS Ratio | 551.41 |
| Price to Book Value | 2.464 |
| Price | 3.06 |
| Earnings Yield | -24.51% |